2026/8/25 In accordance with the provisions of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies

1.Date of occurrence of the event:2026/08/25

2.For the company for whom the endorsements /guarantees were made(1)Company name(2)Its relationship with the Company providing endorsements/ guarantees(3)The ceiling on the endorsements/ guarantees (thousand NTD)(4)The original amount of endorsements/guarantees (thousand NTD)(5)the amount of the current additional endorsements/guarantees (thousand NTD)(6)The amount of endorsements/guarantees as of the dateof occurrence (thousand NTD)(7)The actual loaned amount of the company for whom endorsements/ guarantees were made (thousand NTD)(8)The reason for the current additional endorsements/guarantees:

I.Company name: Tianjin Chase Sun Jiandakang Pharmaceutical Technology Co., Ltd.

IIThe relationship with the Company providing endorsement/guarantee: A reinvestment enterprise in which the Company holds 80.91% equity

III.Upper limit of the endorsement/guarantee (in thousand NT$): 697,848

IV.The remaining balance of original endorsement/guarantee (in thousand NT$): 159,500

V.The amount of new newly added endorsement/guarantee this time (in thousand NT$): 162,741

VI.The remaining balance of endorsement/guarantee as of the date of occurrence (in thousand NT$): 322,241

VII.The actual amount used by the endorsed/guaranteed company (in thousand NT$): 138,381

VIII.Reasons for the newly added endorsement/guarantee this time: The guarantee required to apply for a loan (financing) from financial institutions due to operational needs

3.For collaterals provided by the company for whom the endorsements/guarantees were made, the (1)Content(2)Value (thousand NTD): Contents: To provide a fixed term deposit of US$ 5.1million Value (in thousand NT$):162,741

4.For the latest financial statements of the company for whom the endorsements/guarantees were made, the (1)Capital (thousand NTD)(2)Cumulative gains/losses (thousand NTD): Capital (in thousand NT$):393,322 Accumulated amount of profit and loss (in thousand NT$):-470,182

5.For termination of endorsement/guarantee obligations, the (1)Condition(2)Date: Conditions: Pay off all bank loans or terminate the contract Date:The expiration date of the credit contract or the repayment date of bank loan of the company endorsed/guaranteed

6.The total amount of the ceiling on endorsements/ guarantees (thousand NTD):930,464

7.The total amount of endorsements/guarantees as of the date of occurrence (thousand NTD):322,241

8.The amount of endorsements/guarantees provided by A as a percentage of the public company’s net worth on the latest financial report as of the date of occurrence:13.85

9.The aggregate amount of long-term investments, endorsements/guarantees, and monetary loans extended to others as a percentage of the public company’s net worth on the latest financial statements:34.62

10.Any other matters that need to be specified:

(1)The Board of Directors resolved on August 25, 2026, to provide an endorsement and guarantee quota of USD 5.1 million (approximately NTD 162,741 thousand) for the subsidiary Tianjin Hongri Jiandakang Pharmaceutical Technology Co., Ltd., which is a renewal of the contract as the existing agreement with the cooperating bank is about to expire.

(2)The exchange rate of US$ to NT$: 31.91